6-43605580-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_006502.3(POLH):c.1074+261C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0126 in 151,232 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.013 ( 16 hom., cov: 30)
Consequence
POLH
NM_006502.3 intron
NM_006502.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.681
Genes affected
POLH (HGNC:9181): (DNA polymerase eta) This gene encodes a member of the Y family of specialized DNA polymerases. It copies undamaged DNA with a lower fidelity than other DNA-directed polymerases. However, it accurately replicates UV-damaged DNA; when thymine dimers are present, this polymerase inserts the complementary nucleotides in the newly synthesized DNA, thereby bypassing the lesion and suppressing the mutagenic effect of UV-induced DNA damage. This polymerase is thought to be involved in hypermutation during immunoglobulin class switch recombination. Mutations in this gene result in XPV, a variant type of xeroderma pigmentosum. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]
GTPBP2 (HGNC:4670): (GTP binding protein 2) GTP-binding proteins, or G proteins, constitute a superfamily capable of binding GTP or GDP. G proteins are activated by binding GTP and are inactivated by hydrolyzing GTP to GDP. This general mechanism enables G proteins to perform a wide range of biologic activities.[supplied by OMIM, Jan 2003]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 6-43605580-C-T is Benign according to our data. Variant chr6-43605580-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 1207530.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0126 (1904/151232) while in subpopulation NFE AF = 0.0207 (1404/67818). AF 95% confidence interval is 0.0198. There are 16 homozygotes in GnomAd4. There are 852 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 16 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POLH | NM_006502.3 | c.1074+261C>T | intron_variant | Intron 9 of 10 | ENST00000372236.9 | NP_006493.1 | ||
POLH | NM_001291969.2 | c.702+261C>T | intron_variant | Intron 7 of 8 | NP_001278898.1 | |||
POLH | NM_001291970.2 | c.1074+261C>T | intron_variant | Intron 9 of 10 | NP_001278899.1 | |||
POLH | XM_047418900.1 | c.618+261C>T | intron_variant | Intron 6 of 7 | XP_047274856.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POLH | ENST00000372236.9 | c.1074+261C>T | intron_variant | Intron 9 of 10 | 1 | NM_006502.3 | ENSP00000361310.4 | |||
POLH | ENST00000372226.1 | c.1074+261C>T | intron_variant | Intron 9 of 10 | 1 | ENSP00000361300.1 | ||||
GTPBP2 | ENST00000496137.5 | n.*132-198G>A | intron_variant | Intron 3 of 3 | 3 | ENSP00000436973.1 |
Frequencies
GnomAD3 genomes AF: 0.0126 AC: 1904AN: 151110Hom.: 16 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
1904
AN:
151110
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0126 AC: 1904AN: 151232Hom.: 16 Cov.: 30 AF XY: 0.0115 AC XY: 852AN XY: 73798 show subpopulations
GnomAD4 genome
AF:
AC:
1904
AN:
151232
Hom.:
Cov.:
30
AF XY:
AC XY:
852
AN XY:
73798
Gnomad4 AFR
AF:
AC:
0.00329729
AN:
0.00329729
Gnomad4 AMR
AF:
AC:
0.0106973
AN:
0.0106973
Gnomad4 ASJ
AF:
AC:
0.02194
AN:
0.02194
Gnomad4 EAS
AF:
AC:
0.000977708
AN:
0.000977708
Gnomad4 SAS
AF:
AC:
0.000417885
AN:
0.000417885
Gnomad4 FIN
AF:
AC:
0.00820305
AN:
0.00820305
Gnomad4 NFE
AF:
AC:
0.0207025
AN:
0.0207025
Gnomad4 OTH
AF:
AC:
0.0114395
AN:
0.0114395
Heterozygous variant carriers
0
91
182
272
363
454
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
25
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jul 14, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at